Targeting can be passive or active. Passive targeting exploits the Enhanced Permeability and Retention (EPR) effect, where nanoparticles accumulate in tumor tissues due to leaky vasculature. Active targeting involves functionalizing nanoparticles with ligands or antibodies that bind to specific receptors on target cells, enhancing the precision of drug delivery.
